Company / Total Debt
LEXICON PHARMACEUTICALS, INC. Total Debt History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$49.4M
FY2025
5-year range
$49.4M / $243.9M
FY2021-FY2025
Trend
-50.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Debt has fluctuated over the past 10 years, ranging from $20M in FY2013 to $244M in FY2018.
Based on SEC 10-K filings.
$49M in FY2025 with a 10-year CAGR of -7.2%.
Improved from $100M to $49M over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -7.2%
Key checks
Key Insights
- In FY2025, total debt decreased 50.7% year-over-year.
- Peak total debt was recorded in FY2018.
- Lowest total debt in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $49.4M | -50.7% |
| FY2024 | $100.3M | +0.8% |
| FY2023 | $99.5M | -57.5% |
| FY2019 | $234.2M | -4.0% |
| FY2018 | $243.9M | +5.3% |
| FY2017 | $231.6M | +171.9% |
| FY2016 | $85.2M | -17.9% |
| FY2015 | $103.8M | +18.6% |
| FY2014 | $87.5M | +333.9% |
| FY2013 | $20.2M | -7.8% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026